AstraZeneca (AZN) is up 104.9%, or $97.32 to $190.09.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AZN:
- AstraZeneca reports FDA issued CRL for BLA for subcutaneous Saphnelo
- AstraZeneca, Daiichi Sankyo announce Datroway sBLA granted priority review
- AstraZeneca (AZN) Faces FDA Setback on Lupus Drug with No Change to Sales Outlook
- AstraZeneca rises 106.9%
- AstraZeneca Tests Next-Gen Cell Therapy in Multiple Sclerosis: What Investors Should Watch